| Drug Name |
Fosaprepitant |
| Drug ID |
BADD_D00962 |
| Description |
Fosaprepitant is an intravenously administered antiemetic drug. It is a prodrug of Aprepitant. It aids in the prevention of acute and delayed nausea and vomiting associated with chemotherapy treatment. |
| Indications and Usage |
For the prevention of nausea and vomiting associated with highly emetogenic cancer chemotherapy. |
| Marketing Status |
Prescription; Discontinued |
| ATC Code |
A04AD12 |
| DrugBank ID |
DB06717
|
| KEGG ID |
D10895
|
| MeSH ID |
C579707
|
| PubChem ID |
135413538
|
| TTD Drug ID |
Not Available
|
| NDC Product Code |
71288-418; 67457-888; 71839-104; 16714-120; 43598-948; 70625-311; 68180-690; 72205-083; 69539-181; 63323-972; 72205-026; 60505-6105; 16714-929; 43598-859; 69097-830; 67457-889; 72603-106; 70710-1615; 68001-421; 16729-240; 72205-054; 68001-517; 0591-4385; 0781-3497; 69539-034 |
| Synonyms |
fosaprepitant | Emend for injection | fosaprepitant dimeglumine | L 785,298 | L785,298 | L-785,298 |
